IP Library Granted Patent US 9,593,383
Granted Patent B2
US 9,593,383 · App. 14/268,107 · Granted Mar 14, 2017

Compositions, kits and related methods for the detection and/or monitoring of listeria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,593,383
App. No.
14/268,107
Granted
Mar 14, 2017
Kind
B2
Abstract

Provided are compositions, kits, and methods for the identification of Listeria . In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.

Claims (12)

1. A method for detecting Listeria in a sample, the method comprising:

performing a nucleic acid amplification assay to generate an amplification product from a Listeria nucleic acid using a set of oligonucleotides comprising a T7 provider oligonucleotide and a primer oligonucleotide, wherein the T7 provider oligonucleotide has the sequence consisting of SEQ ID NO:55 and the primer oligonucleotide has the sequence selected from the group consisting of SEQ ID NOs:64, 65, & 68, and

detecting the presence or absence of amplification product utilizing a detection oligonucleotide that specifically hybridizes to the amplification product, wherein the detection oligonucleotide is a molecular torch having the sequence consisting of SEQ ID NO:78,

wherein the presence of the amplification product indicates the presence of Listeria in the sample.

2. The method of claim 1 , wherein the primer oligonucleotide has the sequence consisting of SEQ ID NO:64.

3. The method of claim 1 , wherein the primer oligonucleotide has the sequence consisting of SEQ ID NO:68.

4. The method of claim 1 , wherein the primer oligonucleotide has the sequence consisting of SEQ ID NO:65.

5. The method of claim 1 , wherein, before the step of performing a nucleic acid amplification reaction, there is a nucleic acid purification step.

6. The method of claim 5 , wherein the nucleic acid purification step is a target capture reaction whereby the Listeria nucleic acid is captured to a solid support.

7. The method of claim 6 , wherein the solid support is a magnetic particle.

8. The method of claim 6 , wherein the solid support is attached to an immobilized probe, and wherein the target capture reaction uses a target capture probe.

9. The method of claim 8 , wherein the target capture probe has the sequence consisting of SEQ ID NO:37.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL FRAME 033471 0102 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036126/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2015
From: RESHATOFF, MICHAEL R.; LIVEZEY, KRISTIN W.; HOGAN, JAMES J.
To: GEN-PROBE INCORPORATED
Reel/Frame 035393/0201 →
SECURITY INTEREST Recorded Aug 5, 2014
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 033471/0102 →